Walleye Capital’s Frazier Lifesciences Acquisition Corporation Unit FLACU Stock Holding History

Walleye Capital’s Portfolio FLACU Stock Details FLACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-14,704	Closed	-$149K	–	4015
2022 Q3	$149K	Hold	14,704	–	–	﹤0.01%	2258
2022 Q2	$145K	Hold	14,704	–	–	﹤0.01%	1631
2022 Q1	$147K	Buy	14,704 +506	+4%	+$5.02K	﹤0.01%	1635
2021 Q4	$141K	Buy	14,198 +698	+5%	+$6.99K	﹤0.01%	1584
2021 Q3	$135	Sell	13,500 -4,500	-25%	-$45.1K	﹤0.01%	1265
2021 Q2	$181	Hold	18,000	–	–	0.01%	1079
2021 Q1	$183	Hold	18,000	–	–	0.01%	941
2020 Q4	$187	Buy	+18,000	New	+$188K	0.01%	740

Walleye Capital's FLACU Position: Q4 2022 in Review

Walleye Capital sold out of Frazier Lifesciences Acquisition Corporation Unit (FLACU) in Q4 2022, closing a stake of 14,704 shares — an estimated $149K sold.

Walleye Capital first reported a position in FLACU in Q4 2020 and held it in 8 quarters. The position peaked at $149K in Q3 2022. 0 funds tracked by Wall St. Rank hold FLACU as of Q4 2022.

Walleye Capital reported no remaining Frazier Lifesciences Acquisition Corporation Unit position as of Q4 2022 after selling out during the quarter.
Walleye Capital sold 14,704 Frazier Lifesciences Acquisition Corporation Unit shares in Q4 2022, an estimated $149K.
Walleye Capital first reported a position in Frazier Lifesciences Acquisition Corporation Unit in Q4 2020 and held it in 8 quarters.
Walleye Capital's Frazier Lifesciences Acquisition Corporation Unit position peaked at $149K in Q3 2022.
0 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Unit as of Q4 2022.

Based on Walleye Capital's 13F filing for Q4 2022, filed 14 Feb 2023.